Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Kidney Transplantation | Research

The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients

Authors: Camilla Lorant, Justina Zigmantaviciute, Naima Ali, Ursa Bonnevier, Mattias Tejde, Bengt von Zur-Mühlen, Britt-Marie Eriksson, Anders Bergqvist, Gabriel Westman

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

BK polyomavirus (BKPyV) infection after kidney transplantation can lead to serious complications such as BKPyV-associated nephropathy (BKPyVAN) and graft loss. The aim of this study was to investigate the incidence of BKPyVAN after implementing a BKPyV screening program, to map the distribution of BKPyV genotypes and subtypes in the Uppsala-Örebro region and to identify host and viral risk factors for clinically significant events.

Methods

This single-center prospective cohort study included kidney transplant patients aged ≥ 18 years at the Uppsala University Hospital in Sweden between 2016 and 2018. BKPyV DNA was analyzed in plasma and urine every 3 months until 18 months after transplantation. Also genotype and subtype were determined. A logistic regression model was used to analyze selected risk factors including recipient sex and age, AB0 incompatibility and rejection treatment prior to BKPyVAN or high-level BKPyV DNAemia.

Results

In total, 205 patients were included. Of these, 151 (73.7%) followed the screening protocol with 6 plasma samples, while184 (89.8%) were sampled at least 5 times. Ten (4.9%) patients developed biopsy confirmed BKPyVAN and 33 (16.1%) patients met criteria for high-level BKPyV DNAemia. Male sex (OR 2.85, p = 0.025) and age (OR 1.03 per year, p = 0.020) were identified as significant risk factors for developing BKPyVAN or high-level BKPyV DNAemia. BKPyVAN was associated with increased viral load at 3 months post transplantation (82,000 vs. < 400 copies/mL; p = 0.0029) and with transient, high-level DNAemia (n = 7 (27%); p < 0.0001). The most common genotypes were subtype Ib2 (n = 50 (65.8%)) and IVc2 (n = 20 (26.3%)).

Conclusions

Male sex and increasing age are related to an increased risk of BKPyVAN or high-level BKPyV DNAemia. BKPyVAN is associated with transient, high-level DNAemia but no differences related to viral genotype were detected.
Appendix
Available only for authorised users
Literature
2.
go back to reference Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol. 2006;577:19–45.CrossRefPubMed Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol. 2006;577:19–45.CrossRefPubMed
4.
go back to reference Antonsson A, Green AC, Mallitt KA, O’Rourke PK, Pawlita M, Waterboer T, Neale RE. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of australians. J Gen Virol. 2010;91(Pt 7):1849–53.CrossRefPubMed Antonsson A, Green AC, Mallitt KA, O’Rourke PK, Pawlita M, Waterboer T, Neale RE. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of australians. J Gen Virol. 2010;91(Pt 7):1849–53.CrossRefPubMed
5.
go back to reference Antonsson A, Pawlita M, Feltkamp MC, Bouwes Bavinck JN, Euvrard S, Harwood CA, et al. Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients. J Med Virol. 2013;85(2):327–35.CrossRefPubMed Antonsson A, Pawlita M, Feltkamp MC, Bouwes Bavinck JN, Euvrard S, Harwood CA, et al. Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients. J Med Virol. 2013;85(2):327–35.CrossRefPubMed
6.
go back to reference Laine HK, Waterboer T, Syrjänen K, Grenman S, Louvanto K, Syrjänen S. Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years. Sci Rep. 2023;13(1):879.ADSCrossRefPubMedPubMedCentral Laine HK, Waterboer T, Syrjänen K, Grenman S, Louvanto K, Syrjänen S. Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years. Sci Rep. 2023;13(1):879.ADSCrossRefPubMedPubMedCentral
7.
go back to reference Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis. 1983;147(4):676–84.CrossRefPubMed Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis. 1983;147(4):676–84.CrossRefPubMed
8.
go back to reference Rinaldo CH, Tylden GD, Sharma BN. The human polyomavirus BK (BKPyV): virological background and clinical implications. Apmis. 2013;121(8):728–45.CrossRefPubMed Rinaldo CH, Tylden GD, Sharma BN. The human polyomavirus BK (BKPyV): virological background and clinical implications. Apmis. 2013;121(8):728–45.CrossRefPubMed
9.
go back to reference Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999;67(6):918–22.CrossRefPubMed Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999;67(6):918–22.CrossRefPubMed
10.
go back to reference Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488–96.CrossRefPubMed Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488–96.CrossRefPubMed
11.
go back to reference Ramos E, Drachenberg CB, Portocarrero M, Wali R, Klassen DK, Fink JC et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl. 2002:143– 53. Ramos E, Drachenberg CB, Portocarrero M, Wali R, Klassen DK, Fink JC et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl. 2002:143– 53.
12.
go back to reference Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl International: Official J Eur Soc Organ Transplantation. 2009;22(6):626–34.CrossRef Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl International: Official J Eur Soc Organ Transplantation. 2009;22(6):626–34.CrossRef
13.
go back to reference Sharif A, Alachkar N, Bagnasco S, Geetha D, Gupta G, Womer K, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(8):1320–7.CrossRefPubMedPubMedCentral Sharif A, Alachkar N, Bagnasco S, Geetha D, Gupta G, Womer K, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(8):1320–7.CrossRefPubMedPubMedCentral
14.
go back to reference Hirsch HH, Randhawa PS. BK Polyomavirus in solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13528.CrossRefPubMed Hirsch HH, Randhawa PS. BK Polyomavirus in solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13528.CrossRefPubMed
15.
go back to reference Herrera S, Bernal-Maurandi J, Cofan F, Ventura P, Marcos MA, Linares L et al. BK Virus and Cytomegalovirus coinfections in kidney transplantation and their impact on allograft loss. J Clin Med. 2021;10(17). Herrera S, Bernal-Maurandi J, Cofan F, Ventura P, Marcos MA, Linares L et al. BK Virus and Cytomegalovirus coinfections in kidney transplantation and their impact on allograft loss. J Clin Med. 2021;10(17).
16.
go back to reference Knowles WA, Gibson PE, Gardner SD. Serological typing scheme for BK-like isolates of human polyomavirus. J Med Virol. 1989;28(2):118–23.CrossRefPubMed Knowles WA, Gibson PE, Gardner SD. Serological typing scheme for BK-like isolates of human polyomavirus. J Med Virol. 1989;28(2):118–23.CrossRefPubMed
17.
go back to reference Krumbholz A, Bininda-Emonds OR, Wutzler P, Zell R. Evolution of four BK virus subtypes. Infect Genet Evol. 2008;8(5):632–43.CrossRefPubMed Krumbholz A, Bininda-Emonds OR, Wutzler P, Zell R. Evolution of four BK virus subtypes. Infect Genet Evol. 2008;8(5):632–43.CrossRefPubMed
18.
go back to reference Morel V, Martin E, François C, Helle F, Faucher J, Mourez T, et al. A simple and Reliable Strategy for BK Virus Subtyping and Subgrouping. J Clin Microbiol. 2017;55(4):1177–85.CrossRefPubMedPubMedCentral Morel V, Martin E, François C, Helle F, Faucher J, Mourez T, et al. A simple and Reliable Strategy for BK Virus Subtyping and Subgrouping. J Clin Microbiol. 2017;55(4):1177–85.CrossRefPubMedPubMedCentral
19.
go back to reference Nishimoto Y, Zheng HY, Zhong S, Ikegaya H, Chen Q, Sugimoto C, et al. An Asian origin for subtype IV BK virus based on phylogenetic analysis. J Mol Evol. 2007;65(1):103–11.ADSCrossRefPubMed Nishimoto Y, Zheng HY, Zhong S, Ikegaya H, Chen Q, Sugimoto C, et al. An Asian origin for subtype IV BK virus based on phylogenetic analysis. J Mol Evol. 2007;65(1):103–11.ADSCrossRefPubMed
20.
go back to reference Zheng HY, Nishimoto Y, Chen Q, Hasegawa M, Zhong S, Ikegaya H, et al. Relationships between BK virus lineages and human populations. Microbes Infect. 2007;9(2):204–13.CrossRefPubMed Zheng HY, Nishimoto Y, Chen Q, Hasegawa M, Zhong S, Ikegaya H, et al. Relationships between BK virus lineages and human populations. Microbes Infect. 2007;9(2):204–13.CrossRefPubMed
21.
go back to reference Ikegaya H, Saukko PJ, Tertti R, Metsärinne KP, Carr MJ, Crowley B, et al. Identification of a genomic subgroup of BK Polyomavirus spread in European populations. J Gen Virol. 2006;87(Pt 11):3201–8.CrossRefPubMed Ikegaya H, Saukko PJ, Tertti R, Metsärinne KP, Carr MJ, Crowley B, et al. Identification of a genomic subgroup of BK Polyomavirus spread in European populations. J Gen Virol. 2006;87(Pt 11):3201–8.CrossRefPubMed
22.
go back to reference Nukuzuma S, Takasaka T, Zheng HY, Zhong S, Chen Q, Kitamura T, Yogo Y. Subtype I BK polyomavirus strains grow more efficiently in human renal epithelial cells than subtype IV strains. J Gen Virol. 2006;87(Pt 7):1893–901.CrossRefPubMed Nukuzuma S, Takasaka T, Zheng HY, Zhong S, Chen Q, Kitamura T, Yogo Y. Subtype I BK polyomavirus strains grow more efficiently in human renal epithelial cells than subtype IV strains. J Gen Virol. 2006;87(Pt 7):1893–901.CrossRefPubMed
23.
go back to reference Schwarz A, Linnenweber-Held S, Heim A, Framke T, Haller H, Schmitt C. Viral origin, clinical course, and renal outcomes in patients with BK Virus infection after living-donor renal transplantation. Transplantation. 2016;100(4):844–53.CrossRefPubMed Schwarz A, Linnenweber-Held S, Heim A, Framke T, Haller H, Schmitt C. Viral origin, clinical course, and renal outcomes in patients with BK Virus infection after living-donor renal transplantation. Transplantation. 2016;100(4):844–53.CrossRefPubMed
24.
go back to reference Wunderink HF, De Brouwer CS, Gard L, De Fijter JW, Kroes ACM, Rotmans JI, Feltkamp MCW. Source and relevance of the BK Polyomavirus genotype for infection after kidney transplantation. Open Forum Infect Dis. 2019;6(3):ofz078.CrossRefPubMedPubMedCentral Wunderink HF, De Brouwer CS, Gard L, De Fijter JW, Kroes ACM, Rotmans JI, Feltkamp MCW. Source and relevance of the BK Polyomavirus genotype for infection after kidney transplantation. Open Forum Infect Dis. 2019;6(3):ofz078.CrossRefPubMedPubMedCentral
25.
go back to reference Lorant C, Westman G, Bergqvist A, von Zur-Mühlen B, Eriksson BM. Risk factors for developing BK Virus-Associated Nephropathy: a single-center retrospective cohort study of kidney transplant recipients. Ann Transpl. 2022;27:e934738. Lorant C, Westman G, Bergqvist A, von Zur-Mühlen B, Eriksson BM. Risk factors for developing BK Virus-Associated Nephropathy: a single-center retrospective cohort study of kidney transplant recipients. Ann Transpl. 2022;27:e934738.
26.
go back to reference Hoffman NG, Cook L, Atienza EE, Limaye AP, Jerome KR. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol. 2008;46(8):2671–80.CrossRefPubMedPubMedCentral Hoffman NG, Cook L, Atienza EE, Limaye AP, Jerome KR. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol. 2008;46(8):2671–80.CrossRefPubMedPubMedCentral
27.
go back to reference Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing platforms. Mol Biol Evol. 2018;35(6):1547–9.CrossRefPubMedPubMedCentral Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing platforms. Mol Biol Evol. 2018;35(6):1547–9.CrossRefPubMedPubMedCentral
28.
go back to reference Heinze G, Dunkler D. Five myths about variable selection. Transpl International: Official J Eur Soc Organ Transplantation. 2017;30(1):6–10.CrossRef Heinze G, Dunkler D. Five myths about variable selection. Transpl International: Official J Eur Soc Organ Transplantation. 2017;30(1):6–10.CrossRef
29.
go back to reference Chung BH, Hong YA, Kim HG, Sun IO, Choi SR, Park HS, et al. Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy. Transpl International: Official J Eur Soc Organ Transplantation. 2012;25(6):687–95.CrossRef Chung BH, Hong YA, Kim HG, Sun IO, Choi SR, Park HS, et al. Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy. Transpl International: Official J Eur Soc Organ Transplantation. 2012;25(6):687–95.CrossRef
30.
go back to reference Hirsch HH, Randhawa P. BK virus in solid organ transplant recipients. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2009;9(Suppl 4):S136–46. Hirsch HH, Randhawa P. BK virus in solid organ transplant recipients. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2009;9(Suppl 4):S136–46.
31.
go back to reference Theodoropoulos N, Wang E, Penugonda S, Ladner DP, Stosor V, Leventhal J, et al. BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2013;13(1):197–206.CrossRef Theodoropoulos N, Wang E, Penugonda S, Ladner DP, Stosor V, Leventhal J, et al. BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2013;13(1):197–206.CrossRef
32.
go back to reference Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric renal trials and collaborative studies (NAPRTCS) registry. Clin J Am Soc Nephrol. 2007;2(5):1037–42.CrossRefPubMed Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric renal trials and collaborative studies (NAPRTCS) registry. Clin J Am Soc Nephrol. 2007;2(5):1037–42.CrossRefPubMed
33.
go back to reference Demey B, Tinez C, Francois C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol. 2018;109:6–12.CrossRefPubMed Demey B, Tinez C, Francois C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol. 2018;109:6–12.CrossRefPubMed
34.
go back to reference Masutani K, Ninomiya T, Randhawa P. HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK Viremia. Nephrol Dial Transpl. 2013;28(12):3119–26.CrossRef Masutani K, Ninomiya T, Randhawa P. HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK Viremia. Nephrol Dial Transpl. 2013;28(12):3119–26.CrossRef
35.
go back to reference Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2013;13(1):136–45.CrossRef Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2013;13(1):136–45.CrossRef
36.
go back to reference Matsuda Y, Qazi Y, Iwaki Y. A rapid and efficient method BK Polyomavirus genotyping by high-resolution melting analysis. J Med Virol. 2011;83(12):2128–34.CrossRefPubMed Matsuda Y, Qazi Y, Iwaki Y. A rapid and efficient method BK Polyomavirus genotyping by high-resolution melting analysis. J Med Virol. 2011;83(12):2128–34.CrossRefPubMed
37.
go back to reference Randhawa P, Kant J, Shapiro R, Tan H, Basu A, Luo C. Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection. J Clin Microbiol. 2011;49(12):4072–6.CrossRefPubMedPubMedCentral Randhawa P, Kant J, Shapiro R, Tan H, Basu A, Luo C. Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection. J Clin Microbiol. 2011;49(12):4072–6.CrossRefPubMedPubMedCentral
38.
go back to reference Kant S, Dasgupta A, Bagnasco S, Brennan DC. BK Virus Nephropathy in kidney transplantation: a state-of-the-art review. Viruses. 2022;14(8). Kant S, Dasgupta A, Bagnasco S, Brennan DC. BK Virus Nephropathy in kidney transplantation: a state-of-the-art review. Viruses. 2022;14(8).
39.
go back to reference Hirsch HH, Randhawa P. BK Polyomavirus in solid organ transplantation. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2013;13(Suppl 4):179–88. Hirsch HH, Randhawa P. BK Polyomavirus in solid organ transplantation. Am J Transplantation: Official J Am Soc Transplantation Am Soc Transpl Surg. 2013;13(Suppl 4):179–88.
40.
go back to reference Hassan S, Mittal C, Amer S, Khalid F, Patel A, Delbusto R, et al. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥ 4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience. Transpl Infect Dis. 2014;16(1):55–60.CrossRefPubMed Hassan S, Mittal C, Amer S, Khalid F, Patel A, Delbusto R, et al. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥ 4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience. Transpl Infect Dis. 2014;16(1):55–60.CrossRefPubMed
41.
go back to reference Govind S, Hockley J, Morris C, Almond N. The development and establishment of the 1st WHO BKV International Standard for nucleic acid based techniques. Biologicals. 2019;60:75–84.CrossRefPubMed Govind S, Hockley J, Morris C, Almond N. The development and establishment of the 1st WHO BKV International Standard for nucleic acid based techniques. Biologicals. 2019;60:75–84.CrossRefPubMed
Metadata
Title
The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients
Authors
Camilla Lorant
Justina Zigmantaviciute
Naima Ali
Ursa Bonnevier
Mattias Tejde
Bengt von Zur-Mühlen
Britt-Marie Eriksson
Anders Bergqvist
Gabriel Westman
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09093-7

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue